UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing

Genome Biology, 2022-07, Vol.23 (1), p.1-158, Article 158

2022

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Primary and acquired resistance in lung cancer

Frontiers in oncology, 2023-11, Vol.13, p.1310331-1310331

2023

Link zum Volltext

Verfügbarkeit prüfen

Thymic Malignancies: From Clinical Management to Targeted Therapies

Journal of clinical oncology, 2011-12, Vol.29 (36), p.4820-4827

2011

Link zum Volltext

Verfügbarkeit prüfen

Understanding the Mechanisms of Resistance in EGFR -Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy

International journal of molecular sciences, 2019-08, Vol.20 (16), p.3951

2019

Link zum Volltext

Verfügbarkeit prüfen

A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors

Nature genetics, 2014-08, Vol.46 (8), p.844-849

2014

Link zum Volltext

Verfügbarkeit prüfen

PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer

Journal of clinical oncology, 2009-06, Vol.27 (16), p.2622-2629

2009

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management

Journal of clinical medicine, 2024-03, Vol.13 (6), p.1574

2024

Link zum Volltext

Verfügbarkeit prüfen

A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC

Cancer Immunology, Immunotherapy, 2021-06, Vol.70 (6), p.1667-1678

2021

Link zum Volltext

Verfügbarkeit prüfen

Mutations of epigenetic regulatory genes are common in thymic carcinomas

Scientific reports, 2014-12, Vol.4 (1), p.7336-7336, Article 7336

2014

Link zum Volltext

Verfügbarkeit prüfen

The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response

British journal of cancer, 2018-11, Vol.119 (10), p.1252-1258

2018

Link zum Volltext

Verfügbarkeit prüfen

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients

Molecular cancer, 2021-02, Vol.20 (1), p.32-32, Article 32

2021

Link zum Volltext

Verfügbarkeit prüfen

Implications of KRAS mutations in acquired resistance to treatment in NSCLC

Oncotarget, 2018-01, Vol.9 (5), p.6630-6643

2018

Link zum Volltext

Verfügbarkeit prüfen

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report

BMC cancer, 2019-04, Vol.19 (1), p.410-4, Article 410

2019

Link zum Volltext

Verfügbarkeit prüfen

Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation

Nature communications, 2022-06, Vol.13 (1), p.3298-3298, Article 3298

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular and Functional Key Features and Oncogenic Drivers in Thymic Carcinomas

Cancers, 2023-12, Vol.16 (1), p.166

2023

Link zum Volltext

Verfügbarkeit prüfen

Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer

Frontiers in oncology, 2020-12, Vol.10, p.593831-593831

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results

Frontiers in immunology, 2021-02, Vol.11, p.573156-573156

2021

Link zum Volltext

Verfügbarkeit prüfen

ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach

Cancers, 2022-05, Vol.14 (11), p.2592

2022

Link zum Volltext

Verfügbarkeit prüfen

Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells

Frontiers in cell and developmental biology, 2014-05, Vol.2, p.20-20

2014

Link zum Volltext

Verfügbarkeit prüfen

Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies

Journal of experimental & clinical cancer research, 2022-12, Vol.41 (1), p.343-343

2022

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal Stem Cell in Pancreatic Islet Transplantation

Biomedicines, 2023-05, Vol.11 (5), p.1426

2023

Link zum Volltext

Verfügbarkeit prüfen

Somatic mutations of thymic epithelial tumors with myasthenia gravis

Frontiers in oncology, 2023-08, Vol.13, p.1224491-1224491

2023

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities

Cell death & disease, 2022-11, Vol.13 (11), p.979-979, Article 979

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression

Translational oncology, 2024-03, Vol.41, p.101869-101869, Article 101869

2024

Link zum Volltext

Verfügbarkeit prüfen

Whole genome and transcriptome sequencing of a B3 thymoma

PloS one, 2013-04, Vol.8 (4), p.e60572-e60572

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(86)
Berichte
(1)

Sprache

Englisch
(87)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(65)
Oncology
(45)
Humans
(40)
Female
(25)
Male
(25)
Middle Aged
(23)
Aged
(19)
Mutation
(19)
Tumors
(19)
Adult
(17)
Aged, 80 And Over
(14)
Lung Neoplasms - Genetics
(14)
Carcinoma, Non-Small-Cell Lung - Genetics
(12)
Nsclc
(12)
Thymoma
(12)
Cancer
(11)
Lung Cancer
(11)
Cell Biology
(10)
Lung Neoplasms - Drug Therapy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing

Editorial: Primary and acquired resistance in lung cancer

Thymic Malignancies: From Clinical Management to Targeted Therapies

Understanding the Mechanisms of Resistance in EGFR -Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy

A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors

PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer

Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management

A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC

Mutations of epigenetic regulatory genes are common in thymic carcinomas

The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients

Implications of KRAS mutations in acquired resistance to treatment in NSCLC

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report

Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation

Molecular and Functional Key Features and Oncogenic Drivers in Thymic Carcinomas

Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer

Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results

ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach

Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells

Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies

Mesenchymal Stem Cell in Pancreatic Islet Transplantation

Somatic mutations of thymic epithelial tumors with myasthenia gravis

Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities

Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression

Whole genome and transcriptome sequencing of a B3 thymoma

Suchergebnisse filtern